Stem cell therapy can safely slow progression of relapsing-remitting multiple sclerosis, finds study

by

Autologous hematopoietic stem cell transplantation, or aHSCT for short, is usually used to treat blood cancers, and involves harvesting stem cells from the person’s own bone marrow or blood followed by chemotherapy and antibody treatment.

Leave A Comment

Your email address will not be published. Required fields are marked *